loadpatents
Patent applications and USPTO patent grants for LIEBESCHUETZ; John Walter.The latest application filed is for "pharmaceutical compounds".
Patent | Date |
---|---|
Pharmaceutical Compounds App 20210107908 - JOHNSON; Christopher Norbert ;   et al. | 2021-04-15 |
Meta-benzamidine derivatives as serine protease inhibitors Grant 7,928,137 - Liebeschuetz , et al. April 19, 2 | 2011-04-19 |
Factor Xa inhibitors Grant 7,427,632 - Sheehan , et al. September 23, 2 | 2008-09-23 |
Serine protease inhibitors Grant 7,351,822 - Liebeschuetz , et al. April 1, 2 | 2008-04-01 |
Chemical compounds Grant 7,265,121 - Wiley , et al. September 4, 2 | 2007-09-04 |
Meta-benzamidine derivatives as serine protease inhibitors App 20070155790 - Liebeschuetz; John Walter ;   et al. | 2007-07-05 |
Meta-benzamidine derivatives as serine protease inhibitors Grant 7,220,781 - Liebeschuetz , et al. May 22, 2 | 2007-05-22 |
Serine protease inhibitors Grant 7,053,078 - Liebeschuetz , et al. May 30, 2 | 2006-05-30 |
Factor xa Inhibitors App 20060052606 - Sheehan; Scott Martin ;   et al. | 2006-03-09 |
Serine protease inhibitors Grant 6,946,467 - Liebeschuetz , et al. September 20, 2 | 2005-09-20 |
Serine protease inhibitors Grant 6,936,611 - Liebeschuetz , et al. August 30, 2 | 2005-08-30 |
Serine protease inhibitors Grant 6,900,196 - Liebeschuetz , et al. May 31, 2 | 2005-05-31 |
Serine protease inhibitors Grant 6,878,725 - Liebeschuetz , et al. April 12, 2 | 2005-04-12 |
Serine protease inhibitors Grant 6,855,715 - Liebeschuetz , et al. February 15, 2 | 2005-02-15 |
Compounds App 20050032790 - Liebeschuetz, John Walter ;   et al. | 2005-02-10 |
Chemical compounds App 20050026928 - Wiley, Michael Robert ;   et al. | 2005-02-03 |
Serine protease inhibitors App 20040259868 - Liebeschuetz, John Walter ;   et al. | 2004-12-23 |
Serine protease inhibitors App 20040242656 - Liebeschuetz, John Walter ;   et al. | 2004-12-02 |
Serine protease inhibitors App 20040176363 - Liebeschuetz, John Walter ;   et al. | 2004-09-09 |
Serine protease inhibitors Grant 6,784,182 - Liebeschuetz , et al. August 31, 2 | 2004-08-31 |
Meta-benzamidine derivatives as serine protease inhibitors App 20040143018 - Liebeschuetz, John Walter ;   et al. | 2004-07-22 |
Serine protease inhibitors App 20040142963 - Liebeschuetz, John Walter ;   et al. | 2004-07-22 |
Meta-benzamidine derivatives as serine protease inhibitors Grant 6,740,682 - Liebeschuetz May 25, 2 | 2004-05-25 |
Serine pretease inhibitors App 20030109706 - Liebeschuetz, John Walter ;   et al. | 2003-06-12 |
Serine protease inhibitors App 20030078438 - Liebeschuetz, John Walter ;   et al. | 2003-04-24 |
Serine protease inhibitors App 20030055246 - Liebeschuetz, John Walter ;   et al. | 2003-03-20 |
Serine protease inhibitors App 20020151724 - Liebeschuetz, John Walter ;   et al. | 2002-10-17 |
Meta-benzamidine derivatives as serine protease inhibitors App 20020055522 - Liebeschuetz, John Walter ;   et al. | 2002-05-09 |
1-amino-7-isoquinoline derivatives as serine protease inhibitors App 20020040144 - Liebeschuetz, John Walter ;   et al. | 2002-04-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.